7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,591.53

+303.93

+0.39%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

OTC Markets OTCPK - Delayed Quote USD

Kane Biotech Inc. (KNBIF)

0.0225 0.0000 (0.00%)

At close: October 30 at 4:00:00 PM EDT

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Kane Engages Independent Trading Group as Market Maker

GlobeNewswire 10d ago

KNE.V

KNBIF
0.00%
Kane Biotech Signs Distribution Agreement with The Stevens Company

GlobeNewswire 11d ago

KNE.V

KNBIF
0.00%
Kane to Showcase revyve® at Wounds Canada National Hybrid Conference

GlobeNewswire 12d ago

KNE.V

KNBIF
0.00%
Kane Launches New Corporate Brand and Redesigned Website

GlobeNewswire 12d ago

KNE.V

KNBIF
0.00%
Kane Biotech Announces $250,000 Insider Loan

GlobeNewswire 15d ago

KNE.V

KNBIF
0.00%
Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026

GlobeNewswire 24d ago

KNE.V

KNBIF
0.00%
Kane Biotech to Host Commercial Update Webcast on September 16

GlobeNewswire 1mo ago

KNE.V

KNBIF
0.00%
Kane Biotech Announces Second Quarter 2026 Financial Results

GlobeNewswire 2mo ago

KNE

KNBIF
0.00%
Kane Biotech’s revyve® Research Presented at Military Health System Research Symposium

GlobeNewswire 2mo ago

KNE.V

KNBIF
0.00%
KNE
Kane Biotech Announces Engagement of DNA Advisors

GlobeNewswire 2mo ago

KNE.V

KNBIF
0.00%
KNE
Kane Biotech Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire 3mo ago

KNE.V

KNE

KNBIF
0.00%
Kane Biotech Announces Grant of Stock Options

GlobeNewswire 5mo ago

KNE

KNBIF
0.00%

Performance Overview

Return	KNBIF	S&P/TSX Composite index (^GSPTSE)
YTD	-15.41%	+11.78%
1-Year	-22.41%	+18.03%
3-Year	-55.62%	+88.90%

Mobilize your Website

View Site in Mobile | Classic

Share by: